2010
DOI: 10.1089/fpd.2009.0427
|View full text |Cite
|
Sign up to set email alerts
|

Application of Real-Time Polymerase Chain Reaction in Detection ofEntamoeba histolyticain Pus Aspirates of Liver Abscess Patients

Abstract: Entamoeba histolytica is the second major cause of liver abscess disease in humans, particularly in developing countries. Recently, DNA molecular-based methods have been employed to enhance the detection of E. histolytica in either pus or stool specimens. In this study, the results of real-time polymerase chain reaction (PCR) to detect E. histolytica DNA in pus from liver abscess cases were compared with those of indirect hemagglutination assay on the corresponding serum samples. Bacterial cultures were also p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
8
2

Relationship

4
6

Authors

Journals

citations
Cited by 33 publications
(20 citation statements)
references
References 18 publications
(28 reference statements)
0
20
0
Order By: Relevance
“…The procedures of collecting and handling the serum samples were approved by USM Human Ethical Committee (reference number USMKK/PPP/ JEPem[213.3(10)]). Human serum samples included in this study were divided into four groups: (i) group A, human ALA serum samples (n ϭ 24) with consistent clinical symptoms (i.e., fever, abdominal/right hepatic chest pain, hepatomegaly, and jaundice) and radiological image and IHA-positive results; (ii) group B, human ALA serum samples (n ϭ 14) from patients whose abscesses were positive by real-time PCR for E. histolytica DNA and negative by bacterial culture (the primers and probe sequences were as reported previously [9]); (iii) group C, healthy blood donor serum samples which were negative by IHA (n ϭ 30); (iv) group D, serum samples from patients with other infections (n ϭ 33), i.e., salmonellosis (n ϭ 5), shigellosis (n ϭ 1), Escherichia coli septicemia (n ϭ 2), Staphylococcus sp. septicemia (n ϭ 2), Helicobacter pylori (n ϭ 6), pyogenic liver abscess (n ϭ 4), Stenotrophomonas maltophilia septicemia (n ϭ 1), enteropathogenic E. coli (n ϭ 1), Ascaris lumbricoides (n ϭ 1), Klebsiella pneumoniae (n ϭ 1), and toxoplasmosis (n ϭ 9).…”
Section: Methodsmentioning
confidence: 99%
“…The procedures of collecting and handling the serum samples were approved by USM Human Ethical Committee (reference number USMKK/PPP/ JEPem[213.3(10)]). Human serum samples included in this study were divided into four groups: (i) group A, human ALA serum samples (n ϭ 24) with consistent clinical symptoms (i.e., fever, abdominal/right hepatic chest pain, hepatomegaly, and jaundice) and radiological image and IHA-positive results; (ii) group B, human ALA serum samples (n ϭ 14) from patients whose abscesses were positive by real-time PCR for E. histolytica DNA and negative by bacterial culture (the primers and probe sequences were as reported previously [9]); (iii) group C, healthy blood donor serum samples which were negative by IHA (n ϭ 30); (iv) group D, serum samples from patients with other infections (n ϭ 33), i.e., salmonellosis (n ϭ 5), shigellosis (n ϭ 1), Escherichia coli septicemia (n ϭ 2), Staphylococcus sp. septicemia (n ϭ 2), Helicobacter pylori (n ϭ 6), pyogenic liver abscess (n ϭ 4), Stenotrophomonas maltophilia septicemia (n ϭ 1), enteropathogenic E. coli (n ϭ 1), Ascaris lumbricoides (n ϭ 1), Klebsiella pneumoniae (n ϭ 1), and toxoplasmosis (n ϭ 9).…”
Section: Methodsmentioning
confidence: 99%
“…PCR technology also facilitates efforts toward identification of E. histolytica in samples other than stool, e.g., aspirates from liver abscesses, cerebrospinal fluid (CSF), and urine (51,(68)(69)(70). The wider availability of real-time PCR platforms has paved the way for the routine use of PCRs for this and other parasite targets as first-line diagnostic methods.…”
Section: Entamoebamentioning
confidence: 99%
“…They were nevertheless, found to be inadequate in highly endemic regions and new detection methodologies such as antigen detection ELISA and polymerase chain reaction (PCR) have since been developed Othman et al 2010;Ackers 2002;Tanyuksel and Petri 2003). Both techniques are widely used nowadays for detecting and identifying E. histolytica in clinical samples.…”
Section: Introductionmentioning
confidence: 99%